The Patent Finder

Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles

Genzyme Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/US2016/013947, filed Jan 19, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,429,288Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
In force
 · High confidence
UsedRemaining
Genzyme CorporationIn forceHigh confidence
US 11,639,887Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 12,013,326Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
In force
 · Medium confidence
Genzyme CorporationIn forceMedium confidence
US 12,031,894Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
In force
 · Medium confidence
Genzyme CorporationIn forceMedium confidence
US 12,085,494Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
In force
 · Medium confidence
Genzyme CorporationIn forceMedium confidence
US 11,267,924Crosslinked Polydiallymine Copolymers for the Treatment of Type 2 Diabetes
Lapsed Mar 8, 2026 on the fee record
High confidence
Genzyme CorporationLapsed Mar 8, 2026 on the fee recordHigh confidence
Application 15/325,290Main Chain Polyamines
Abandoned
Abandoned Oct 22, 2018
Genzyme CorporationAbandonedAbandoned Oct 22, 2018
Application 15/508,738CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS
Abandoned
Abandoned Dec 4, 2018
Genzyme CorporationAbandonedAbandoned Dec 4, 2018
Application 18/797,302Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
Pending
Not granted
Genzyme CorporationPendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Genzyme Corporation.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited